Drug Shortage Report for OXYTOCIN INJECTION, USP
Report ID | 160656 |
Drug Identification Number | 02139561 |
Brand name | OXYTOCIN INJECTION, USP |
Common or Proper name | Oxytocin Injection, USP Synthetic 10 USP units/mL SD Vial 1 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | OXYTOCIN |
Strength(s) | 10UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1mL |
ATC code | H01BB |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-05-01 |
Estimated end date | 2023-04-30 |
Actual end date | 2023-04-01 |
Shortage status | Resolved |
Updated date | 2023-04-05 |
Company comments | On 100% allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-05-15 | English | Compare |
v2 | 2022-05-15 | French | Compare |
v3 | 2022-08-19 | English | Compare |
v4 | 2022-08-19 | French | Compare |
v5 | 2022-09-26 | English | Compare |
v6 | 2022-09-26 | French | Compare |
v7 | 2022-11-02 | English | Compare |
v8 | 2022-11-02 | French | Compare |
v9 | 2022-12-07 | English | Compare |
v10 | 2022-12-07 | French | Compare |
v11 | 2023-03-01 | English | Compare |
v12 | 2023-03-01 | French | Compare |
v13 | 2023-04-05 | English | Compare |
v14 | 2023-04-05 | French | Compare |
Showing 1 to 14 of 14